Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J de Visser

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Frontiers in Artificial Intelligence|December 8, 2025
Robots in the moral loop: a field study of AI advisors in ethical military decision-makingChad C Tossell, Christopher Kuennen, Ali Momen, et al.
Frontiers in Psychology|November 5, 2021
Measurement of Trust in Automation: A Narrative Review and Reference GuideSpencer C Kohn, Ewart J de Visser, Eva Wiese, et al.
Small (Weinheim an Der Bergstrasse, Germany)|February 17, 2023
Orbiting Self-Organization of Filament-Tethered Surface-Active DropletsMitch Winkens, Alexandru Vilcan, Pieter J de Visser, et al.
Nature Communications|February 6, 2014
Fluctuations in the electron system of a superconductor exposed to a photon fluxP J de Visser, J J A Baselmans, J Bueno, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 4, 2024
Drug pricing models, no 'one-size-fits-all' approach: a systematic review and critical evaluation of pricing models in an evolving pharmaceutical landscapeEvert A Manders, Sibren van den Berg, Saco J de Visser, et al.
Human Factors|August 17, 2019
Trust and Distrust of Automated Parking in a Tesla Model XNathan L Tenhundfeld, Ewart J de Visser, Anthony J Ries, et al.
British Journal of Clinical Pharmacology|April 22, 2005
Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjectsG J H Dumont, S J de Visser, A F Cohen, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 7, 2026
Repurposing biosimilars, rethinking costs: a framework for sustainable drug pricing for repurposed bevacizumab for intravitreal injectionsEvert A Manders, Vincent van Der Wel, Reinier Schlingemann, et al.
Journal of Psychopharmacology (Oxford, England)|July 23, 2003
REM sleep effects as a biomarker for the effects of antidepressants in healthy volunteersB Rijnbeek, S J de Visser, K L Franson, et al.
Scientific Reports|January 3, 2023
Customizing virtual interpersonal skills training applications may not improve trainee performanceGale M Lucas, Johnathan Mell, Jill Boberg, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Frontiers in Artificial Intelligence|December 8, 2025
Robots in the moral loop: a field study of AI advisors in ethical military decision-makingChad C Tossell, Christopher Kuennen, Ali Momen, et al.
Frontiers in Psychology|November 5, 2021
Measurement of Trust in Automation: A Narrative Review and Reference GuideSpencer C Kohn, Ewart J de Visser, Eva Wiese, et al.
Small (Weinheim an Der Bergstrasse, Germany)|February 17, 2023
Orbiting Self-Organization of Filament-Tethered Surface-Active DropletsMitch Winkens, Alexandru Vilcan, Pieter J de Visser, et al.
Nature Communications|February 6, 2014
Fluctuations in the electron system of a superconductor exposed to a photon fluxP J de Visser, J J A Baselmans, J Bueno, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 4, 2024
Drug pricing models, no 'one-size-fits-all' approach: a systematic review and critical evaluation of pricing models in an evolving pharmaceutical landscapeEvert A Manders, Sibren van den Berg, Saco J de Visser, et al.
Human Factors|August 17, 2019
Trust and Distrust of Automated Parking in a Tesla Model XNathan L Tenhundfeld, Ewart J de Visser, Anthony J Ries, et al.
British Journal of Clinical Pharmacology|April 22, 2005
Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjectsG J H Dumont, S J de Visser, A F Cohen, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 7, 2026
Repurposing biosimilars, rethinking costs: a framework for sustainable drug pricing for repurposed bevacizumab for intravitreal injectionsEvert A Manders, Vincent van Der Wel, Reinier Schlingemann, et al.
Journal of Psychopharmacology (Oxford, England)|July 23, 2003
REM sleep effects as a biomarker for the effects of antidepressants in healthy volunteersB Rijnbeek, S J de Visser, K L Franson, et al.
Scientific Reports|January 3, 2023
Customizing virtual interpersonal skills training applications may not improve trainee performanceGale M Lucas, Johnathan Mell, Jill Boberg, et al.
Pageof 8